Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain.
Vaccine
; 31(46): 5486-94, 2013 Nov 04.
Article
en En
| MEDLINE
| ID: mdl-24004465
Palabras clave
13-Valent pneumococcal conjugate vaccine; 13-valent pneumococcal conjugate vaccine; 50% tissue culture infectious dose; 7-valent pneumococcal conjugate vaccine; AE; CI; CRM(197); ELISA; GMC; GMT; Haemophilus influenzae type b; Hib; IPD; IgG; Immunogenicity; Infants; MMR; MnC; MnC conjugate vaccine using diphtheria toxin cross-reactive material 197; MnCCV-CRM(197); PCV13; PCV7; Pneumococcal vaccination; SAE; SBA; Spain; TCID(50); adverse event; confidence interval; cross-reactive material 197 (nontoxic mutant form of diphtheria toxin); e-diary; electronic diary; enzyme-linked immunosorbent assay; geometric mean concentration; geometric mean titer; immunoglobulin G; invasive pneumococcal disease; measles, mumps, rubella (vaccine); meningococcal group C; serious adverse event; serum bactericidal assay
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Vacunación
/
Vacunas Meningococicas
/
Vacunas Neumococicas
Tipo de estudio:
Clinical_trials
Límite:
Female
/
Humans
/
Infant
/
Male
País/Región como asunto:
Europa
Idioma:
En
Revista:
Vaccine
Año:
2013
Tipo del documento:
Article
Pais de publicación:
Países Bajos